Abbott receives FDA approval and CE Mark for new ICD lead

Abbott has received regulatory clearance for a new implantable cardioverter-defibrillator (ICD) lead, obtaining both U.S. FDA approval and the CE Mark for the European market.

Detected & updated continuously · Source: Nebula